Institute For Nuclear Medical entered the industry of Health Services in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $2.500.000 to $4.999.999. The NAICS classifies this business under the code 3391120, which describes it as a Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Health Services. The business provides service to the B2C market.
To acquire more information, please contact Charles Rose, Owner by calling (303) 541-0044 during business hours. You can also write to the business’ Single Location at 1143 Peakview Circle, Boulder, Colorado CO 80302. You can also visit the company’s website at nuclearcardiology.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Institute For Nuclear Medical |
| Representative: | Charles Rose, Owner |
| Place of Business: | 1143 Peakview Circle, Boulder, CO 80302 |
| Contact Number: | (303) 541-0044 |
| Website: | nuclearcardiology.com |
| Type of Service: | Health Services |
| SIC Number: | 8099 |
| NAICS Number: | 3391120 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2010 |
| Income/Year: | $2.500.000 to $4.999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Institute For Nuclear Medical is a company operating from Boulder, Colorado providing professional Health Services and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8099 as Health Services, and with the NAICS code 3391120 as Health Services.
With a current employee count of 1 to 4, Institute For Nuclear Medical has gone to report making $2.500.000 to $4.999.999 per annum on its journey towards growth. This company invites you to contact its representative Charles Rose, Owner at (303) 541-0044 for related queries, or to locate its Single Location using the coordinates 40.099316,-105.328031.
The Single Location can also be found at the street address 1143 Peakview Circle in Boulder, Colorado 80302 and can be engaged online through the company website at nuclearcardiology.com, the company Twitter , and Facebook page .